SHH · 600539.SS
Lionhead Technology Development Co., Ltd.
CN¥11.62-CN¥0.40 (-3.33%)
Lionhead Technology Development Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.7% below the high.
Loading market information…
SHZ · 002742.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Chongqing Jiheng Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 46.31% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Chongqing Jiheng Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.04 per share, paid annual. The forward yield is 1.19% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Chongqing Jiheng Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Chongqing Sansheng Industrial Co.,Ltd. is a Chinese enterprise specializing in the research, development, production, and sale of a diverse range of products, spanning both building materials and chemicals, as well as pharmaceuticals. Within its building materials and chemical segment, the company supplies essential construction inputs such as commercial concrete, water-reducing agents, and expansion agents. These products find extensive application across various large-scale infrastructure projects, including industrial and residential buildings, highways, railways, bridges, tunnels, airports, and water conservancy facilities. Additionally, Sansheng Industrial manufactures sulfuric acid, a key chemical component vital for the production of chemical fertilizers, general industrial chemicals, light industry products, textiles, steel, and water reducer formulations, among other non-fertilizer acidic compounds. The company also maintains a significant presence in the pharmaceutical sector. Its offerings here encompass pharmaceutical intermediates, exemplified by procaine hydrochloride, cefoxitin intermediate, chloramphenicol intermediate, aztreonam intermediate, and orlistat intermediate, which are crucial precursors for antibiotic drugs, anti-hepatitis C treatments, diabetes medications, specific penicillin variants, and cosmetic formulations. Furthermore, Sansheng produces active pharmaceutical ingredients (APIs) such as acetaminophen, cloperidine hydrochloride, levofloxacin mesylate, benoate, and diphenhydramine hydrochloride. Its range of finished pharmaceutical preparations includes compound paracetamol diphenhydramine, clarithromycin sustained-release, diclofenac sodium enteric-coated, and famotidine tablets, designed for diverse therapeutic applications like antipyretic and analgesic effects, antiviral, antibacterial, cough relief, allergy management, and local anesthesia. Beyond these, the company provides a selection of clinically significant drugs, including famotidine, diclofenac sodium, nifedipine, acetaminophen, furosemide, and norfloxacin. Established in 2002, the company was initially known as Chongqing Sansheng Special Building Materials Co., Ltd. before officially adopting its current name, Chongqing Sansheng Industrial Co.,Ltd., in October 2016. Its operations are headquartered in Chongqing, China.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 01:41 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥11.62-CN¥0.40 (-3.33%)
Lionhead Technology Development Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.7% below the high.
CN¥21.08-CN¥1.16 (-5.22%)
Newtechwood Corp’s quoted price sits in the lower half of its reported 52-week range, 63.11% below the high.
CN¥3.91+CN¥0.36 (+10.14%)
Suzhou Yangtze New Materials Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.25% below the high.
CN¥10.47-CN¥0.47 (-4.3%)
Chongqing Sifang New Material Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.39% below the high.
CN¥17.00-CN¥0.81 (-4.55%)
Jiangsu Huaxin New Material Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.03% below the high.
CN¥4.54-CN¥0.22 (-4.62%)
Beijing Hanjian Heshan Pipeline Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 50.97% below the high.
CN¥4.26-CN¥0.14 (-3.18%)
Shanxi Tond Chemical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.06% below the high.
CN¥6.66-CN¥0.16 (-2.35%)
Yunnan Bowin Technology Industry Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 31.9% below the high.
